Dong Liang, Ph.D.
Professor and Chair, Department of Pharmaceutical and Environmental Health Sciences, TSU COPHS.
Dr. Liang has industrial and academic expertise in pre-clinical and Phase I PK and drug development studies. He has worked on Phase I PK studies from protocol design (clinical study monitoring; bioanalysis; and statistical PK data interpretation) to FDA submissions for over 35 generic drug product approvals. He is co-inventor of 5 U.S. patents in dosage formulation development. He is the Director of CCPF with responsibility for the overall operations of the program, as well as providing support in PK studies in rats.
Area of Expertise
Fusce est leo, dapibus non pellentesque sed, scelerisque nec sapien. In accumsan efficitur gravida. Nam eget neque quis nisi pulvinar molestie.
- Growth Strategy
- Business Information
- Financial Planning
- Money Transaction Guide
- Stock and trading Strategy
Quisque in lorem vitae ligula congue tincidunt. Vestibulum et sem et neque cursus viverra a ac lectus.
My Skills
Sed imperdiet libero mollis, tincidunt odio et, tristique nisi. Vivamus nec diam vitae nisi varius pulvinar.